Search Results - "Ho, Ivy A"
-
1
Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness
Published in Oncogene (01-07-2019)“…Glioblastoma (GBM) is the most aggressive tumor of the brain. NF1 , a tumor suppressor gene and RAS-GTPase, is one of the highly mutated genes in GBM…”
Get full text
Journal Article -
2
Human Bone Marrow‐Derived Mesenchymal Stem Cells Suppress Human Glioma Growth Through Inhibition of Angiogenesis
Published in Stem cells (Dayton, Ohio) (01-01-2013)“…Tumor tropism of human bone marrow‐derived mesenchymal stem cells (MSC) has been exploited for the delivery of therapeutic genes for anticancer therapy…”
Get full text
Journal Article -
3
Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
Published in Nature communications (04-12-2017)“…The interleukin-13 receptor alpha2 (IL-13Rα2) is a cancer-associated receptor overexpressed in human glioblastoma multiforme (GBM). This receptor is…”
Get full text
Journal Article -
4
Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
Published in BioMed research international (01-01-2017)“…Glioblastoma is the most aggressive cancer of the brain. The dismal prognosis is largely attributed to the heterogeneous nature of the tumor, which in addition…”
Get full text
Journal Article -
5
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
Published in BMC cancer (11-04-2015)“…The treatment of glioblastoma multiforme (GBM) is an unmet clinical need. The 5-year survival rate of patients with GBM is less than 3%. Temozolomide (TMZ)…”
Get full text
Journal Article -
6
Paracrine Factors of Human Fetal MSCs Inhibit Liver Cancer Growth Through Reduced Activation of IGF-1R/PI3K/Akt Signaling
Published in Molecular therapy (01-04-2015)“…Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death in the world. The multikinase inhibitor sorafenib only demonstrated marginal…”
Get full text
Journal Article -
7
Matrix Metalloproteinase 1 Is Necessary for the Migration of Human Bone Marrow‐Derived Mesenchymal Stem Cells Toward Human Glioma
Published in Stem cells (Dayton, Ohio) (01-06-2009)“…Human mesenchymal stem cells (MSCs) have increasingly been used as cellular vectors for the delivery of therapeutic genes to tumors. However, the precise…”
Get full text
Journal Article -
8
Matrix metalloproteinase‐1‐mediated mesenchymal stem cell tumor tropism is dependent on crosstalk with stromal derived growth factor 1/C‐X‐C chemokine receptor 4 axis
Published in The FASEB journal (01-10-2014)“…Human bone marrow‐derived mesenchymal stem cells (MSCs) have the unique ability to home toward injuries or tumor sites. We have previously shown that the…”
Get full text
Journal Article -
9
Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis
Published in Molecular cancer research (01-07-2007)“…Angiopoietins (ANG-1 and ANG-2) and their TIE-2 receptor tyrosine kinase have wide-ranging effects on tumor malignancy that includes angiogenesis,…”
Get full text
Journal Article -
10
FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors
Published in Molecular cancer (13-10-2010)“…Glioblastoma multiforme is the most malignant cancer of the brain and is notoriously difficult to treat due to the highly proliferative and infiltrative nature…”
Get full text
Journal Article -
11
Isolation of peptide ligands that interact specifically with human glioma cells
Published in Peptides (New York, N.Y. : 1980) (01-04-2010)“…Poor prognosis of high grade gliomas coupled with the difficulty of widespread delivery of therapeutic agents prompted the search into new molecular targets…”
Get full text
Journal Article -
12
Recent Advances in Glioma Therapy: Combining Vascular Normalization and Immune Checkpoint Blockade
Published in Cancers (22-07-2021)“…Glioblastoma (GBM) accounts for more than 50% of all primary malignancies of the brain. Current standard treatment regimen for GBM includes maximal surgical…”
Get full text
Journal Article -
13
Hybrid herpes simplex virus/Epstein-Barr virus amplicon viral vectors confer enhanced transgene expression in primary human tumors and human bone marrow-derived mesenchymal stem cells
Published in The journal of gene medicine (01-10-2010)“…Background Herpes simplex virus type‐1 (HSV‐1) amplicon vectors are attractive tools for gene transfer because of their large DNA insert capacity, their broad…”
Get full text
Journal Article -
14
Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma
Published in Stem cells and development (01-07-2013)“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been used extensively in cancer therapy. However, more than half of glioblastoma multiforme…”
Get more information
Journal Article -
15
Signaling molecules and pathways involved in MSC tumor tropism
Published in Histology and histopathology (01-11-2013)“…Human bone marrow is a reservoir containing cells with different self-renewal capabilities, such as mesenchymal stem cells (MSC) and hematopoeitic stem cells…”
Get full text
Journal Article -
16
Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells
Published in Human gene therapy (01-03-2007)“…We previously generated a herpes simplex virus type 1 (HSV-1)-based amplicon vector (denoted pC8-36) in which gene expression from the minimal cyclin A…”
Get more information
Journal Article -
17
Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP5+, Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme
Published in Stem cell reviews (01-02-2016)“…Glioblastoma multiforme is the most malignant tumor of the brain and is challenging to treat due to its highly invasive nature and heterogeneity. Malignant…”
Get full text
Journal Article -
18
Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration
Published in Journal of virological methods (01-02-2007)“…Herpes simplex virus (HSV)-1 amplicon vectors could be packaged in the presence of replication-competent helper virus or in a helper virus-free system. In the…”
Get full text
Journal Article -
19
An Efficient and Safe Herpes Simplex Virus Type 1 Amplicon Vector for Transcriptionally Targeted Therapy of Human Hepatocellular Carcinomas
Published in Molecular therapy (01-06-2007)“…Our previous studies have shown that transgene expression could be targeted to proliferating cells when cell cycle transcriptional regulatory elements were…”
Get full text
Journal Article -
20
Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector
Published in Human gene therapy (01-05-2004)“…We have engineered a novel herpes simplex virus type 1 (HSV-1)-based amplicon viral vector, whereby gene expression is controlled by cell cycle events. In…”
Get more information
Journal Article